跳至主要内容
临床试验/CTRI/2023/01/048921
CTRI/2023/01/048921招募中未知

An investigation into metabolomics of prostate cancer patients to identify diagnostic and prognostic biomarkers for disease burden and therapeutic outcome, and development of metabolomics database

AIIMS New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1) Patients aged >= 18 years
  • 2) Prostate cancer Any T, any N, M0 or M1

排除标准

  • 1.Patients who are not willing to participate and will not provide signed informed consent
  • 2.Patients with metabolic disorders
  • 3.Thyrotoxicosis patients
  • 4.Patients with uncontrolled DM, defined as HbA1c >=7.5%
  • 5.Patients with hepatic dysfunction that is those in whom serum bilirubin will be more than 1.5 and, AST and ALT will be more than 2.5 fold higher than the upper limit of normal at baseline
  • 6.Patients in whom serum creatinine will be more than 1.5 fold higher than the upper limit of normal

研究者

发起方
AIIMS New Delhi

相似试验